NCT03345537View on ClinicalTrials.gov

Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

February 12, 2018

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions
Optic Neuritis
Interventions
OTHER

Non interventional study

Non interventional study - only data collected and one blood sample additional

Trial Locations (8)

Unknown

Chu Angers, Angers

Ch Challans, Challans

Ch Cholet, Cholet

Chd La Roche Sur Yon, La Roche-sur-Yon

Ch Laval, Laval

Chr Le Mans, Le Mans

CHU Nantes, Nantes

Ch Saint Nazaire, Saint-Nazaire

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT03345537 - Initial Clinical Presentation of Inflammatory Optic Neuritis Associated or Not With Autoantibodies Anti-Myelin-oligodendrocyte-glycoprotein | Biotech Hunter | Biotech Hunter